Pfizer Inc. buy Guggenheim
Start price
17.12.25
/
50%
€21.74
Target price
17.12.26
-
Performance (%)
5.63%
Price
12:54
€22.97
Summary
This prediction is currently active. The BUY prediction by Guggenheim shows slight gains of 5.63%. This prediction currently runs until 17.12.26. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Pfizer Inc. | -1.544% | -1.544% |
| iShares Core DAX® | 0,61 % | 0,34 % |
| iShares Nasdaq 100 | 0,64 % | -3,17 % |
| iShares Nikkei 225® | -0,13 % | 8,92 % |
| iShares S&P 500 | 0,54 % | -0,70 % |
Comments by Guggenheim for this prediction
In the thread Pfizer Inc. diskutieren
Pfizer (NYSE:PFE) had its "buy" rating reaffirmed by analysts at Guggenheim.
Ratings data for PFE provided by MarketBeat